| scholarly article | Q13442814 |
| P50 | author | Michael Hornsey | Q43201899 |
| P2093 | author name string | David W Wareham | |
| P2860 | cites work | Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells | Q21263068 |
| Inorganic polyphosphate is needed for swimming, swarming, and twitching motilities of Pseudomonas aeruginosa | Q24676026 | ||
| Monoclonal antibodies against the iron regulated outer membrane Proteins of Acinetobacter baumannii are bactericidal | Q24803309 | ||
| Microbial synergy via an ethanol-triggered pathway | Q27938765 | ||
| Molecular mechanisms of ethanol-induced pathogenesis revealed by RNA-sequencing | Q28394612 | ||
| The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation | Q33487075 | ||
| Dissection of host cell signal transduction during Acinetobacter baumannii-triggered inflammatory response | Q33552294 | ||
| Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions | Q33826851 | ||
| Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. | Q33976675 | ||
| Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. | Q51818859 | ||
| The effect of ISAba1-mediated adeN gene disruption on Acinetobacter baumannii pathogenesis. | Q52682049 | ||
| Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. | Q53953981 | ||
| Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance. | Q54458242 | ||
| Acinetobacter baumannii resistant to everything: what should we do? | Q58386822 | ||
| Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like | Q84974548 | ||
| Functions of the mismatch repair gene mutS from Acinetobacter sp. strain ADP1. | Q33997106 | ||
| Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure | Q34019104 | ||
| Fitness cost of chromosomal drug resistance-conferring mutations | Q34107494 | ||
| Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy | Q34184603 | ||
| Patients with Acinetobacter baumannii bloodstream infections are colonized in the gastrointestinal tract with identical strains | Q34443686 | ||
| The biological cost of mutational antibiotic resistance: any practical conclusions? | Q34554396 | ||
| Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling. | Q34574281 | ||
| Acinetobacter baumannii: emergence of a successful pathogen | Q34795807 | ||
| Acinetobacter baumannii Repeatedly Evolves a Hypermutator Phenotype in Response to Tigecycline That Effectively Surveys Evolutionary Trajectories to Resistance | Q35816112 | ||
| A fitness cost associated with the antibiotic resistance enzyme SME-1 beta-lactamase | Q35945753 | ||
| c-di-GMP-mediated regulation of virulence and biofilm formation | Q36701663 | ||
| Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group | Q36744796 | ||
| The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner | Q36849931 | ||
| Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance | Q37667216 | ||
| Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy | Q37788421 | ||
| Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. | Q37869910 | ||
| Prevalence of hypermutators among clinical Acinetobacter baumannii isolates | Q38270541 | ||
| Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins | Q38491423 | ||
| Polymyxin Resistance in Gram-negative Pathogens | Q40051834 | ||
| Structural Modification of Lipopolysaccharide Conferred by mcr-1 in Gram-Negative ESKAPE Pathogens. | Q40266237 | ||
| Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells | Q40344085 | ||
| The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host. | Q41363141 | ||
| Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients. | Q41763114 | ||
| Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics | Q42025783 | ||
| Membrane permeability, a pivotal function involved in antibiotic resistance and virulence in Enterobacter aerogenes clinical isolates | Q42493717 | ||
| Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii | Q42747669 | ||
| AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii | Q43017225 | ||
| xBASE2: a comprehensive resource for comparative bacterial genomics. | Q43032299 | ||
| Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital | Q43756833 | ||
| Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii | Q44959125 | ||
| The in vitro fitness cost of antimicrobial resistance in Escherichia coli varies with the growth conditions. | Q50053573 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Acinetobacter baumannii | Q3241189 |
| P304 | page(s) | 4234 | |
| P577 | publication date | 2018-03-09 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Effects of In vivo Emergent Tigecycline Resistance on the Pathogenic Potential of Acinetobacter baumannii. | |
| P478 | volume | 8 |
| Q63727116 | Methods and Challenges of Using the Greater Wax Moth () as a Model Organism in Antimicrobial Compound Discovery | cites work | P2860 |
Search more.